特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
952481

肝臓がん治療の世界市場:がんの種類別、治療法別、機器別、年齢別、要因別、投与経路別、流通経路別、地域別の競合情勢、予測、機会

Global Liver Cancer Therapeutics Market, By Cancer Type, By Therapy, By Equipment, By Age, By Factors, By Route of Administration, By Distribution channel, By Region, Competition, Forecast & Opportunities, 2025

出版日: | 発行: TechSci Research | ページ情報: 英文 129 Pages | 納期: お問合せ

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

肝臓がん治療の世界市場:がんの種類別、治療法別、機器別、年齢別、要因別、投与経路別、流通経路別、地域別の競合情勢、予測、機会
出版日: 2020年08月01日
発行: TechSci Research
ページ情報: 英文 129 Pages
納期: お問合せ
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の肝臓がん治療市場は、今後の着実に成長を続け、2025年には110億米ドルに達すると予測されています。市場拡大の原動力となるのは、世界的な肝臓がん患者の増加、アルコール消費量の増加、高齢化、公共部門と民間部門の両方から治療法の研究開発に対して投入される資金の増加などの要因です。肝臓がんは、肝臓の細胞で始まる慢性的で生命を脅かす病気です。ほとんどの肝臓がん患者は初期段階では症状を示しませんが、後期段階では、食欲不振、上腹部の痛み、吐き気と嘔吐、皮膚の黄色の変色などの症状を呈します。世界がん研究基金によると、肝臓がんは世界で6番目に多いがんだといいます。肝臓がんの増加のもう1つの主な理由は、HBV / HCVの同時感染と肝硬変の発生率上昇です。

当レポートは、世界の肝臓がん治療市場を調査したもので、新型コロナウイルス感染症(COVID-19)パンデミックの影響、世界と各地域市場の展望、市場の力学、主なトレンド、競合情勢などの情報を提供しています。

目次

第1章 製品の概要

第2章 調査手法

第3章 COVID-19の影響

第4章 顧客の声

第5章 エグゼクティブサマリー

第6章 市場の展望

  • 市場規模と予測
    • 金額ベース
  • 市場シェアと予測
    • がんの種類別(肝細胞がん、胆管がん、肝芽腫、血管肉腫、肝転移)
    • 治療法別(標的療法、化学療法と放射線療法、免疫療法、その他)
    • 機器別(コンピュータラジオグラフィー、ソノグラフィー、MRI、その他)
    • 年齢別(0-18歳、18-35歳、35-50歳、50歳超)
    • 要因別(肝硬変、非アルコール性脂肪肝疾患、過度のアルコール消費、その他)
    • 投与経路別(経口、点滴、その他)
    • 流通チャネル別(病院薬局、小売薬局、オンライン薬局)
    • 企業別
    • 地域別
  • 市場魅力指数

第7章 アジア太平洋市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • がんの種類別
    • 治療法別
    • 機器別
    • 年齢別
    • 要因別
    • 投与経路別
    • 国別
  • 国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第8章 欧州市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • がんの種類別
    • 治療法別
    • 機器別
    • 年齢別
    • 要因別
    • 投与経路別
    • 国別
  • 国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第9章 北米

  • 市場規模と予測
  • 市場シェアと予測
    • がんの種類別
    • 治療法別
    • 機器別
    • 年齢別
    • 要因別
    • 投与経路別
    • 国別
  • 国別分析
    • 米国
    • メキシコ
    • カナダ

第10章 南米

  • 市場規模と予測
  • 市場シェアと予測
    • がんの種類別
    • 治療法別
    • 機器別
    • 年齢別
    • 要因別
    • 投与経路別
    • 国別
  • 国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第11章 中東とアフリカ

  • 市場規模と予測
  • 市場シェアと予測
    • がんの種類別
    • 治療法別
    • 機器別
    • 年齢別
    • 要因別
    • 投与経路別
    • 国別
  • 国別分析
    • 南アフリカ
    • サウジアラビア
    • UAE

第12章 市場の力学

  • 促進要因
  • 課題

第13章 市場の動向

第14章 競合情勢

  • 競合の展望
  • 主要企業のプロファイル
    • AbbVie Inc.
    • Alnylam Pharmaceuticals Inc.
    • Amgen Inc.
    • AstraZeneca
    • Bayer AG
    • Bristol-Myers Squibb Company
    • Celsion Corporation
    • Eisai Co., Ltd.
    • Eli Lilly and Company
    • Exelixis, Inc.
    • F. Hoffmann-La Roche AG
    • Johnson & Johnson
    • Merck
    • Novartis International AG
    • Perkin Elmer
    • Pfizer Inc.
    • Philips Healthcare Pvt. Ltd
    • Sanofi S.A.
    • Sun Pharmaceutical Industries Ltd.

第15章 戦略的提言

第16章 免責事項

図表

List of Figures

  • Figure 1: Global Liver Cancer Therapeutic Market Size, By Value, 2015-2025F (USD Million)
  • Figure 2: Global Per Capita Health Expenditure, In USD, 2015-2019
  • Figure 3: Global Liver Cancer Therapeutic Market Share, By Cancer Type, By Value, 2015-2025F
  • Figure 4: Global Liver Cancer Therapeutic Market Share, By Therapy, By Value, 2015-2025F
  • Figure 5: Global Liver Cancer Therapeutic Market Share, By Equipment, By Value, 2015-2025F
  • Figure 6: Global Liver Cancer Therapeutic Market Share, By Age, By Value, 2015-2025F
  • Figure 7: Global Liver Cancer Therapeutic Market Share, By Factors, By Value, 2015-2025F
  • Figure 8: Global Liver Cancer Therapeutic Market Share, By Route of Administration, By Value, 2019 & 2025F
  • Figure 9: Global Liver Cancer Therapeutic Market Share, By Distribution Channel, By Value, 2019 & 2025F
  • Figure 10: Global Liver Cancer Therapeutic Market Share, By Region, By Value, 2019 & 2025F
  • Figure 11: Global Liver Cancer Therapeutic Market Share, By Company, By Value, 2019
  • Figure 12: Global Liver Cancer Therapeutics Market Size (USD Billion) & Growth Rate (%), By Cancer Type, 2020E-2025F
  • Figure 13: Global Liver Cancer Therapeutics Market Size (USD Billion) & Growth Rate (%), By Therapy, 2020E-2025F
  • Figure 14: Global Liver Cancer Therapeutics Market Size (USD Billion) & Growth Rate (%), By Region, 2020E-2025F
  • Figure 15: Asia-Pacific Liver Cancer Therapeutic Market Size, By Value, 2015-2025F (USD Million)
  • Figure 16: Asia Pacific Liver Cancer Therapeutics Market Share, By Cancer Type, By Value, 2015-2025F
  • Figure 17: Asia Pacific Liver Cancer Therapeutic Market Share, By Therapy, By Value, 2015-2025F
  • Figure 18: Asia Pacific Liver Cancer Therapeutic Market Share, By Equipment, By Value, 2015-2025F
  • Figure 19: Asia Pacific Liver Cancer Therapeutic Market Share, By Age, By Value, 2015-2025F
  • Figure 20: Asia Pacific Cancer Therapeutic Market Share, By Factors, By Value, 2015-2025F
  • Figure 21: Asia Pacific Liver Cancer Therapeutic Market Share, By Route of Administration, By Value, 2019 & 2025F
  • Figure 22: Asia Pacific Liver Cancer Therapeutic Market Share, By Country, By Value, 2019 & 2025F
  • Figure 23: Japan Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)
  • Figure 24: Japan Total Health Expenditure as a share of GDP, 2015- 2019
  • Figure 25: Japan Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
  • Figure 26: Japan Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
  • Figure 27: Japan Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
  • Figure 28: Japan Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
  • Figure 29: Japan Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
  • Figure 30: Japan Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
  • Figure 31: China Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)
  • Figure 32: China Number of Health Checks, By Volume, 2012, 2015, 2017, 2019, 2020E, 2025F (Billion)
  • Figure 33: China Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
  • Figure 34: China Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
  • Figure 35: China Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
  • Figure 36: China Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
  • Figure 37: China Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
  • Figure 38: China Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
  • Figure 39: India Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)
  • Figure 40: India No of Hospitalized Cases For The Treatment of Patients, 2008, 2013 & 2019
  • Figure 41: India Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
  • Figure 42: India Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
  • Figure 43: India Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
  • Figure 44: India Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
  • Figure 45: India Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
  • Figure 46: India Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
  • Figure 47: South Korea Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Billion)
  • Figure 48: South Korea Per Capita Expenditure On Health, By Value, '000 USD, 2015-2020E
  • Figure 49: South Korea Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
  • Figure 50: South Korea Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
  • Figure 51: South Korea Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
  • Figure 52: South Korea Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
  • Figure 53: South Korea Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
  • Figure 54: South Korea Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
  • Figure 55: Australia Liver Cancer Therapeutics Market Size, By Value 2015-2025F (USD Billion)
  • Figure 56: Australia Enterprise Healthcare Spending, By Value (USD Billion) 2017-2021E
  • Figure 57: Australia Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
  • Figure 58: Australia Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
  • Figure 59: Australia Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
  • Figure 60: Australia Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
  • Figure 61: Australia Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
  • Figure 62: Australia Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
  • Figure 63: Europe Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Billion)
  • Figure 64: Europe Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
  • Figure 65: Europe Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
  • Figure 66: Europe Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
  • Figure 67: Europe Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
  • Figure 68: Europe Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
  • Figure 69: Europe Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
  • Figure 70: Europe Liver Cancer Therapeutics Market Size, By Country, 2015-2025F
  • Figure 71: Germany Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Billion)
  • Figure 72: Germany New Cases of Cancer, By Type, 2019
  • Figure 73: Germany Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
  • Figure 74: Germany Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
  • Figure 75: Germany Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
  • Figure 76: Germany Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
  • Figure 77: Germany Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
  • Figure 78: Germany Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
  • Figure 79: France Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)
  • Figure 80: France Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
  • Figure 81: France Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
  • Figure 82: France Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
  • Figure 83: France Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
  • Figure 84: France Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
  • Figure 85: France Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
  • Figure 86: United Kingdom Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)
  • Figure 87: United Kingdom Healthcare Spending, By Value (USD Per Capita), 2015-2018
  • Figure 88: United Kingdom Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
  • Figure 89: United Kingdom Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
  • Figure 90: United Kingdom Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
  • Figure 91: United Kingdom Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
  • Figure 92: United Kingdom Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
  • Figure 93: United Kingdom Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
  • Figure 94: Italy Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)
  • Figure 95: Italy Per Capita Expenditure On Health, By Value, '000 USD, 2015-2020E
  • Figure 96: Italy Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
  • Figure 97: Italy Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
  • Figure 98: Italy Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
  • Figure 99: Italy Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
  • Figure 100: Italy Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
  • Figure 101: Italy Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
  • Figure 102: Spain Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)
  • Figure 103: Spain Hospital Beds, By Volume, 2014-2020E
  • Figure 104: Spain Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
  • Figure 105: Spain Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
  • Figure 106: Spain Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
  • Figure 107: Spain Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
  • Figure 108: Spain Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
  • Figure 109: Spain Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
  • Figure 110: North America Liver Cancer Therapeutics Market Size, By Value
  • Figure 111: North America Health Spending Share, By Value, 2020E
  • Figure 112: North America Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
  • Figure 113: North America Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
  • Figure 114: North America Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
  • Figure 115: North America Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
  • Figure 116: North America Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
  • Figure 117: North America Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
  • Figure 118: North America Liver Cancer Therapeutics Market Size, By Country, 2015-2025F
  • Figure 119: United States Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)
  • Figure 120: United States Healthcare Spending, By Value, 2018 -2021F (USD Per Capita)
  • Figure 121: United States Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
  • Figure 122: United States Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
  • Figure 123: United States Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
  • Figure 124: United States Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
  • Figure 125: United States Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
  • Figure 126: United States Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
  • Figure 127: Canada Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)
  • Figure 128: Canada Hospital Establishments, By Region, 2019 (Units)
  • Figure 129: Canada Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
  • Figure 130: Canada Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
  • Figure 131: Canada Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
  • Figure 132: Canada Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
  • Figure 133: Canada Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
  • Figure 134: Canada Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
  • Figure 135: Mexico Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)
  • Figure 136: Mexico Promotional Mortality (Percentage of All Deaths, By Disease, 2019
  • Figure 137: Mexico Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
  • Figure 138: Mexico Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
  • Figure 139: Mexico Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
  • Figure 140: Mexico Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
  • Figure 141: Mexico Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
  • Figure 142: Mexico Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
  • Figure 143: South America Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Billion)
  • Figure 144: South America Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
  • Figure 145: South America Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
  • Figure 146: South America Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
  • Figure 147: South America Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
  • Figure 148: South America Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
  • Figure 149: South America Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
  • Figure 150: South America Liver Cancer Therapeutics Market Size, By Country, 2015-2025F
  • Figure 151: Brazil Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)
  • Figure 152: Brazil Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
  • Figure 153: Brazil Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
  • Figure 154: Brazil Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
  • Figure 155: Brazil Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
  • Figure 156: Brazil Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
  • Figure 157: Brazil Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
  • Figure 158: Argentina Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)
  • Figure 159: Argentina, Per Capita Health Expenditure, By Sector (USD), 2020E
  • Figure 160: Argentina Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
  • Figure 161: Argentina Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
  • Figure 162: Argentina Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
  • Figure 163: Argentina Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
  • Figure 164: Argentina Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
  • Figure 165: Argentina Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
  • Figure 166: Colombia Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)
  • Figure 167: Colombia Healthcare Expenditure, By Value, USD Billion, 2015-2020E
  • Figure 168: Colombia Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
  • Figure 169: Colombia Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
  • Figure 170: Colombia Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
  • Figure 171: Colombia Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
  • Figure 172: Colombia Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
  • Figure 173: Colombia Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
  • Figure 174: Middle East & Africa Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Billion)
  • Figure 175: Middle East & Africa Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
  • Figure 176: Middle East & Africa Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
  • Figure 177: Middle East & Africa Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
  • Figure 178: Middle East & Africa Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
  • Figure 179: Middle East & Africa Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
  • Figure 180: Middle East & Africa Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
  • Figure 181: Middle East & Africa Liver Cancer Therapeutics Market Size, By Country, 2015-2025F
  • Figure 182: South Africa Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)
  • Figure 183: South Africa per Capita Health Expenditure, 2014-2016, 2019 & 2020E (USD)
  • Figure 184: South Africa Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
  • Figure 185: South Africa Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
  • Figure 186: South Africa Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
  • Figure 187: South Africa Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
  • Figure 188: South Africa Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
  • Figure 189: South Africa Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
  • Figure 190: Saudi Arabia Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)
  • Figure 191: Saudi Arabia Healthcare Budget, By Value (USD Billion),2018 & 2019
  • Figure 192: Saudi Arabia Covid-19 Cumulative Statistics, By Value, Till 13th May 2020
  • Figure 193: Saudi Arabia Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
  • Figure 194: Saudi Arabia Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
  • Figure 195: Saudi Arabia Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
  • Figure 196: Saudi Arabia Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
  • Figure 197: Saudi Arabia Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
  • Figure 198: Saudi Arabia Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
  • Figure 199: UAE Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)
  • Figure 200: UAE Healthcare Expenditure, By Value (USD Billion), 2018, 2019, 2023F & 2028F
  • Figure 201: UAE Covid-19 Cumulative Statistics, By Value, Till 13th May 2020
  • Figure 202: UAE Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
  • Figure 203: UAE Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
  • Figure 204: UAE Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
  • Figure 205: UAE Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
  • Figure 206: UAE Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
  • Figure 207: UAE Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
目次
Product Code: 4667

Global liver cancer therapeutics market is forecast to grow in the coming years and reach $ 11 billion by 2025. Major factors behind the growth of this market include rising cases of liver cancer, globally, increasing alcohol consumption, aging population, and growing funding by both public and private sector in research and development activities for cancer cure. Liver cancer is a chronic and life-threatening disease which begins in cells of liver. Most of the liver cancer patients do not show the symptoms at early stages but in later stages, the common symptoms include loss of appetite, upper abdominal pain, nausea and vomiting and yellow discoloration of skin. According to World Cancer Research Fund, liver cancer is the sixth most common cancer across the globe. Another major reason for the increase in the liver cancer is the high increase in the incidence of HBV/HCV coinfection and cirrhosis. Therefore, scientists are working on developing more innovative drugs and therapies for liver cancer treatment. However, the market also faces some restrains. Expensive treatments as well as high cost in research and development might hamper further development of liver cancer therapeutics market.

The global liver cancer therapeutics market is segmented based on cancer type, therapy, equipment, age, factors, route of administration, distribution channel and region. Based on route of administration, the market is segmented into oral, intravenous and others. The oral segment is anticipated to dominate the global liver cancer therapeutics market during the forecast period as it is most preferred route of administration for chemotherapy. Based on distribution channel the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. The hospital pharmacies are anticipated to dominate the market during the forecast period as the drugs are mostly purchased from the hospitals at the time of treatment. Based on therapy the market is segmented into chemotherapy and radiation therapy, immunotherapy, targeted therapy, and others. The chemotherapy and radiation therapy segment is anticipated to dominate the market through 2025.

The onset of COVID-19 has adversely impacted the market on account of significantly lower patient footfall in private clinics and hospital OPDs. Major players operating in the global liver cancer therapeutics market include Bayer AG, Alnylam Pharmaceuticals Inc., F. Hoffmann-La Roche AG , Bristol-Myers Squibb Company, Eisai Co., Ltd. , Pfizer Inc., Exelixis, Inc., Merck, Celsion Corporation, Johnson & Johnson, Novartis International AG, Sanofi S.A., Eli Lilly and Company, Perkin Elmer, Sun Pharmaceutical Industries Ltd., AbbVie Inc., Amgen Inc., AstraZeneca, Philips Healthcare Pvt. Ltd and others.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study:

  • To analyze and forecast the market size of global liver cancer therapeutics market.
  • To classify and forecast global liver cancer therapeutics market based on cancer type, therapy, equipment, age, factors, route of administration, distribution channel and region.
  • To identify drivers and challenges for global liver cancer therapeutics market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global liver cancer therapeutics market.
  • To conduct pricing analysis for global liver cancer therapeutics market.
  • To identify and analyze the profile of leading players operating in global liver cancer therapeutics market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of leading players operating across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include market players, which could not be identified due to the limitations of secondary research. TechSci Research analyzed the market players, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global liver cancer therapeutics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Liver cancer therapeutics players and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to liver cancer therapeutics
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as market players, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global liver cancer therapeutics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Cancer Type:

Hepatocellular Carcinoma

Cholangiocarcinoma

Hepatoblastoma

Angiosarcoma

Liver Metastasis

  • Market, By Therapy:

Targeted Therapy

Chemotherapy and Radiation Therapy

Immunotherapy

Others

  • Market, By Equipment:

Computed Radiography

Sonography

MRI

Others

  • Market, By Age:

0-18

18-35

35-50

50+

  • Market, By Factors:

Cirrhosis

Nonalcoholic Fatty Liver Disease

Excessive Alcohol Consumption

Others

  • Market, By Route of Administration:

Oral

Intravenous

Others

  • Market, By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

  • Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global liver cancer therapeutics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Liver Cancer Therapeutics Market

4. Voice of Customer

5. Executive Summary

6. Global Liver Cancer Therapeutics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Cancer Type (Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatoblastoma, Angiosarcoma, Liver Metastasis)
    • 6.2.2. By Therapy (Targeted Therapy, Chemotherapy and Radiation Therapy, Immunotherapy, Others)
    • 6.2.3. By Equipment (Computed Radiography, Sonography, MRI, Others)
    • 6.2.4. By Age (0-18, 18-35, 35-50, 50+)
    • 6.2.5. By Factors (Cirrhosis, Nonalcoholic Fatty Liver Disease, Excessive Alcohol Consumption, Others)
    • 6.2.6. By Route of Administration (Oral, Intravenous, Others)
    • 6.2.7. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
    • 6.2.8. By Company (2019)
    • 6.2.9. By Region
  • 6.3. Market Attractiveness Index

7. Asia-Pacific Liver Cancer Therapeutics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Cancer Type
    • 7.2.2. By Therapy
    • 7.2.3. By Equipment
    • 7.2.4. By Age
    • 7.2.5. By Factors
    • 7.2.6. By Route of Administration
    • 7.2.7. By Country
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China Liver Cancer Therapeutics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Cancer Type
        • 7.3.1.2.2. By Therapy
        • 7.3.1.2.3. By Equipment
        • 7.3.1.2.4. By Age
        • 7.3.1.2.5. By Factors
        • 7.3.1.2.6. By Route of Administration
    • 7.3.2. India Liver Cancer Therapeutics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Cancer Type
        • 7.3.2.2.2. By Therapy
        • 7.3.2.2.3. By Equipment
        • 7.3.2.2.4. By Age
        • 7.3.2.2.5. By Factors
        • 7.3.2.2.6. By Route of Administration
    • 7.3.3. Japan Liver Cancer Therapeutics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Cancer Type
        • 7.3.3.2.2. By Therapy
        • 7.3.3.2.3. By Equipment
        • 7.3.3.2.4. By Age
        • 7.3.3.2.5. By Factors
        • 7.3.3.2.6. By Route of Administration
    • 7.3.4. South Korea Liver Cancer Therapeutics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Cancer Type
        • 7.3.4.2.2. By Therapy
        • 7.3.4.2.3. By Equipment
        • 7.3.4.2.4. By Age
        • 7.3.4.2.5. By Factors
        • 7.3.4.2.6. By Route of Administration
    • 7.3.5. Australia Liver Cancer Therapeutics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Cancer Type
        • 7.3.5.2.2. By Therapy
        • 7.3.5.2.3. By Equipment
        • 7.3.5.2.4. By Age
        • 7.3.5.2.5. By Factors
        • 7.3.5.2.6. By Route of Administration

8. Europe Liver Cancer Therapeutics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Cancer Type
    • 8.2.2. By Therapy
    • 8.2.3. By Equipment
    • 8.2.4. By Age
    • 8.2.5. By Factors
    • 8.2.6. By Route of Administration
    • 8.2.7. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Liver Cancer Therapeutics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Cancer Type
        • 8.3.1.2.2. By Therapy
        • 8.3.1.2.3. By Equipment
        • 8.3.1.2.4. By Age
        • 8.3.1.2.5. By Factors
        • 8.3.1.2.6. By Route of Administration
    • 8.3.2. Germany Liver Cancer Therapeutics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Cancer Type
        • 8.3.2.2.2. By Therapy
        • 8.3.2.2.3. By Equipment
        • 8.3.2.2.4. By Age
        • 8.3.2.2.5. By Factors
        • 8.3.2.2.6. By Route of Administration
    • 8.3.3. United Kingdom Liver Cancer Therapeutics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Cancer Type
        • 8.3.3.2.2. By Therapy
        • 8.3.3.2.3. By Equipment
        • 8.3.3.2.4. By Age
        • 8.3.3.2.5. By Factors
        • 8.3.3.2.6. By Route of Administration
    • 8.3.4. Italy Liver Cancer Therapeutics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Cancer Type
        • 8.3.4.2.2. By Therapy
        • 8.3.4.2.3. By Equipment
        • 8.3.4.2.4. By Age
        • 8.3.4.2.5. By Factors
        • 8.3.4.2.6. By Route of Administration
    • 8.3.5. Spain Liver Cancer Therapeutics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Cancer Type
        • 8.3.5.2.2. By Therapy
        • 8.3.5.2.3. By Equipment
        • 8.3.5.2.4. By Age
        • 8.3.5.2.5. By Factors
        • 8.3.5.2.6. By Route of Administration

9. North America Liver Cancer Therapeutics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Cancer Type
    • 9.2.2. By Therapy
    • 9.2.3. By Equipment
    • 9.2.4. By Age
    • 9.2.5. By Factors
    • 9.2.6. By Route of Administration
    • 9.2.7. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Liver Cancer Therapeutics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Cancer Type
        • 9.3.1.2.2. By Therapy
        • 9.3.1.2.3. By Equipment
        • 9.3.1.2.4. By Age
        • 9.3.1.2.5. By Factors
        • 9.3.1.2.6. By Route of Administration
    • 9.3.2. Mexico Liver Cancer Therapeutics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Cancer Type
        • 9.3.2.2.2. By Therapy
        • 9.3.2.2.3. By Equipment
        • 9.3.2.2.4. By Age
        • 9.3.2.2.5. By Factors
        • 9.3.2.2.6. By Route of Administration
    • 9.3.3. Canada Liver Cancer Therapeutics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Cancer Type
        • 9.3.3.2.2. By Therapy
        • 9.3.3.2.3. By Equipment
        • 9.3.3.2.4. By Age
        • 9.3.3.2.5. By Factors
        • 9.3.3.2.6. By Route of Administration

10. South America Liver Cancer Therapeutics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Cancer Type
    • 10.2.2. By Therapy
    • 10.2.3. By Equipment
    • 10.2.4. By Age
    • 10.2.5. By Factors
    • 10.2.6. By Route of Administration
    • 10.2.7. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Liver Cancer Therapeutics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Cancer Type
        • 10.3.1.2.2. By Therapy
        • 10.3.1.2.3. By Equipment
        • 10.3.1.2.4. By Age
        • 10.3.1.2.5. By Factors
        • 10.3.1.2.6. By Route of Administration
    • 10.3.2. Argentina Liver Cancer Therapeutics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Cancer Type
        • 10.3.2.2.2. By Therapy
        • 10.3.2.2.3. By Equipment
        • 10.3.2.2.4. By Age
        • 10.3.2.2.5. By Factors
        • 10.3.2.2.6. By Route of Administration
    • 10.3.3. Colombia Liver Cancer Therapeutics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Cancer Type
        • 10.3.3.2.2. By Therapy
        • 10.3.3.2.3. By Equipment
        • 10.3.3.2.4. By Age
        • 10.3.3.2.5. By Factors
        • 10.3.3.2.6. By Route of Administration

11. Middle East and Africa Liver Cancer Therapeutics Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Cancer Type
    • 11.2.2. By Therapy
    • 11.2.3. By Equipment
    • 11.2.4. By Age
    • 11.2.5. By Factors
    • 11.2.6. By Route of Administration
    • 11.2.7. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Liver Cancer Therapeutics Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Cancer Type
        • 11.3.1.2.2. By Therapy
        • 11.3.1.2.3. By Equipment
        • 11.3.1.2.4. By Age
        • 11.3.1.2.5. By Factors
        • 11.3.1.2.6. By Route of Administration
    • 11.3.2. Saudi Arabia Liver Cancer Therapeutics Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Cancer Type
        • 11.3.2.2.2. By Therapy
        • 11.3.2.2.3. By Equipment
        • 11.3.2.2.4. By Age
        • 11.3.2.2.5. By Factors
        • 11.3.2.2.6. By Route of Administration
    • 11.3.3. UAE Liver Cancer Therapeutics Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Cancer Type
        • 11.3.3.2.2. By Therapy
        • 11.3.3.2.3. By Equipment
        • 11.3.3.2.4. By Age
        • 11.3.3.2.5. By Factors
        • 11.3.3.2.6. By Route of Administration

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Players Profiled (Leading Companies)
    • 14.2.1. AbbVie Inc.
    • 14.2.2. Alnylam Pharmaceuticals Inc.
    • 14.2.3. Amgen Inc.
    • 14.2.4. AstraZeneca
    • 14.2.5. Bayer AG
    • 14.2.6. Bristol-Myers Squibb Company
    • 14.2.7. Celsion Corporation
    • 14.2.8. Eisai Co., Ltd.
    • 14.2.9. Eli Lilly and Company
    • 14.2.10. Exelixis, Inc.
    • 14.2.11. F. Hoffmann-La Roche AG
    • 14.2.12. Johnson & Johnson
    • 14.2.13. Merck
    • 14.2.14. Novartis International AG
    • 14.2.15. Perkin Elmer
    • 14.2.16. Pfizer Inc.
    • 14.2.17. Philips Healthcare Pvt. Ltd
    • 14.2.18. Sanofi S.A.
    • 14.2.19. Sun Pharmaceutical Industries Ltd.

15. Strategic Recommendations

16. About Us & Disclaimer

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.